Selegiline Hydrochloride

This page contains recent news articles, when available, and an overview of Selegiline Hydrochloride but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

… of Federal Regulations - 21 CFR § 520.2098 Selegiline hydrochloride...  -  Jul 11, 2006
21 CFR § 520.2098 Selegiline hydrochloride tablets. (a) Specifications. Each tablet contains either 2, 5, 10, 15, or 30 milligrams of selegiline ... Pay-Per-View - United States Code of Federal Regulation... - Loislaw

Why hasn't neuroprotection worked in Parkinson's disease?  -  Dec 13, 2006
The most notable of these studies have been of selegiline hydrochloride with or without vitamin E, 1, 2 riluzole, 3 coenzyme Q10, 4 and, recently, ... Nature.com

Monoamine Oxidase Inhibition for Tobacco Pharmacotherapy  -  Oct 5, 2007
George, TP, Vessicchio, JC, Termine, A., Jatlow, PI, Kosten, TR & O'Malley, SS A preliminary placebo-controlled trial of selegiline hydrochloride for ... Nature.com

Manganese-Induced Parkinsonism Associated With Methcathinone ( …  -  Dec 22, 2006
Trials of selegiline hydrochloride and levodopa-carbidopa at doses up to 600/150 mg/d were ineffective. Magnetic resonance images of the brain showed ... Archives of Neurology

VRX Receives Approvable Letter from FDA  -  Oct 4, 2005
...for Zelapar (selegiline hydrochloride). The approvable letter requests additional clarification on specific issues previously addressed by Valeant. ... StreetInsider.com - StreetInsider.com (subscription)

Valeant Pharmaceuticals submits complete response to FDA approvable …  -  Jan 5, 2005
Zelapar (selegiline hydrochloride) is a late-stage candidate under review by the FDA as an oral tablet using the patented Zydis fast-dissolving technology ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com

Brain Scans, Genes Provide Addiction Clues  -  Apr 4, 2007
A preliminary 8-week randomized placebo-controlled trial of selegiline hydrochloride showed promising results (Geor. Journal of American Medical Association - Journal of American Medical Association...

Gary Bogue: Today is a good day to keep your cool!  -  Jul 9, 2008
Although it is not yet approved for cats, there is a medication available for dogs (selegiline hydrochloride) which can be used off-label in cats. ... $2.95 - Oakland Tribune - NewsBank

Merger and Acquisition Scenario  -  Oct 14, 2006
Symmetrel (Amantadine Hydrochloride); Frova (Frovatriptan Succinate); Endo Generics Carbidopa/Levodopa; Endo Generics Selegiline Hydrochloride ... $250.00 - Revere Reports - Revere

Pathological Crying Caused by High-Frequency Stimulation in the...  -  Apr 12, 2007
5 mg of selegiline hydrochloride, and 6 mg of pramipexole dihydrochloride daily. Structured preoperative neuropsychiatric evaluation and brain imaging ... Archives of Neurology

The Malignant Course of "Benign Hallucinations" in Parkinson Disease  -  Jan 4, 2006
Other agents were infrequently prescribed (anticholinergics, 0%; amantadine hydrochloride, 6%; selegiline hydrochloride, 27%; catechol-O-methyl-transferase ... Archives of Neurology

Business Update; Company submits response to US FDA approvable …  -  Jan 31, 2005
Zelapar (selegiline hydrochloride) is a late-stage candidate under review by the FDA as an oral tablet using the patented Zydis fast-dissolving technology ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones

Merger and Acquisition Scenario  -  Aug 19, 2006
Symmetrel (Amantadine Hydrochloride); Frova (Frovatriptan Succinate); Endo Generics Carbidopa/Levodopa; Endo Generics Selegiline Hydrochloride ... $250.00 - Revere Reports - Revere

Business Update; Company submits response to US FDA approvable …  -  Feb 5, 2005
Zelapar (selegiline hydrochloride) is a late-stage candidate under review by the FDA as an oral tablet using the patented Zydis fast-dissolving technology ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

Illinois Administrative Code - 86 Ill. Adm. Code 530.110 Covered …  -  Aug 10, 2005
7) Pergolide Mesylate 8) Selegiline Hydrochloride 9) Entacapone 10) Tolcapone 11) Dopaminergics 12) Clonazepam g) Drugs purchased on or after January 1, ... Pay-Per-View - Illinois Administrative Code - Loislaw

Research targets conditions of older cats and dogs  -  Aug 15, 2006
Drugs such as selegiline hydrochloride, as well as the specially formulated diet Canine b/d, are now available for the management of cognitive dysfunction ... American Veterinary Medical Association

Merger and Acquisition Scenario  -  Sep 2, 2006
Symmetrel (Amantadine Hydrochloride); Frova (Frovatriptan Succinate); Endo Generics Carbidopa/Levodopa; Endo Generics Selegiline Hydrochloride ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Aug 19, 2006
Symmetrel (Amantadine Hydrochloride); Frova (Frovatriptan Succinate); Endo Generics Carbidopa/Levodopa; Endo Generics Selegiline Hydrochloride ... $250.00 - Revere Reports - Revere

Pharmacology and pharmacokinetics of rasagiline: a selective, …  -  Aug 1, 2006
Rasagiline mesylate has a molecular weight of 267.34, which is similar to that of selegiline hydrochloride, 223.75. In vitro human brain homogenate ... $4.95 - Formulary - ECNext





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy